Hasil Pencarian - Satrajit Roychoudhury

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Case–control matching‐guided exposure‐efficacy relationship for avelumab in patients with urothelial carcinoma

    Case–control matching‐guided exposure‐efficacy relationship for avelumab in patients with urothelial carcinoma oleh Pooneh Soltantabar, Ali Alhadab, Jennifer Hibma, Satrajit Roychoudhury, Diane D. Wang, Carlo Bello, Mohamed Elmeliegy

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity

    Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity oleh Bart Heeg, Andre Verhoek, Gabriel Tremblay, Ofir Harari, Mohsen Soltanifar, Haitao Chu, Satrajit Roychoudhury, Joseph C Cappelleri

    Diterbitkan 2023-01-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis

    The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis oleh Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lisy Wang, Lara Fallon, Satrajit Roychoudhury, Yves Brault, Meriem Kessouri

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles

    Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles oleh Kelley M. Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, John Scott, Tara Moroz, Shaoming Yin, Madhurima Majumder, John Zhong, Raymond A. Huml, Veronica Miller

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

    Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study oleh Prisha Patel, Judith C. Macdonald, Jayanthi Boobalan, Matthew Marsden, Ruben Rizzi, Marianne Zenon, Jinma Ren, Haitao Chu, Joseph C. Cappelleri, Satrajit Roychoudhury, Julie O’Brien, Konoha Izaki-Lee, Konoha Izaki-Lee, Donna Boyce

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: